SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-295412
Filing Date
2018-10-09
Accepted
2018-10-09 09:14:06
Documents
9
Period of Report
2018-10-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d624442d8k.htm 8-K 27902
2 EXHIBIT 1.1 d624442dex11.htm EX-1.1 147230
3 EXHIBIT 4.1 d624442dex41.htm EX-4.1 99867
4 EXHIBIT 4.2 d624442dex42.htm EX-4.2 100695
5 EX-5.1 d624442dex51.htm EX-5.1 12375
6 EXHIBIT 10.1 d624442dex101.htm EX-10.1 157695
7 EXHIBIT 99.1 d624442dex991.htm EX-99.1 27674
8 GRAPHIC g624442dsp99_1.jpg GRAPHIC 3713
9 GRAPHIC g624442g43v83.jpg GRAPHIC 2790
  Complete submission text file 0001193125-18-295412.txt   584044
Mailing Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878
Business Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878 2406541450
Altimmune, Inc. (Filer) CIK: 0001326190 (see all company filings)

IRS No.: 202726770 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32587 | Film No.: 181112399
SIC: 2834 Pharmaceutical Preparations